autonomic nervous system disease: A disease involving the autonomic nervous system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
779 |
4. Check minimum number of eventsNone |
779 |
5. Include endpoints |
801 |
6. Filter based on genotype QC (FinnGen only) |
801 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G90-G99
- Name in latin
- Morbositates systematis nervosi autonomici
Similar endpoints
↥List of similar endpoints to
Autonomic disorders
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6006 | 2906 | 3053 |
| Only index persons | 5139 | 2553 | 2586 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.09 |
| Only index persons | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 56.80 | 57.86 | 55.60 |
| Only index persons | 55.36 | 56.45 | 54.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 801 | 429 | 372 |
| Unadjusted period prevalence (%) | 0.15 | 0.15 | 0.16 |
| Median age at first event (years) | 56.53 | 55.19 | 58.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 712
- Matched controls
- 7119
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G90.2
ICD-10 Finland
Horner syndrome
+∞
323.0
394
*
G90.0
ICD-10 Finland
Idiopathic peripheral autonomic neuropathy
+∞
115.9
108
*
G90.3
ICD-10 Finland
Multi-system degeneration
961.6
88.7
85
*
G90.9
ICD-10 Finland
Disorder of autonomic nervous system, unspecified
592.6
56.4
55
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
35.6
43.6
56
17
G90.8
ICD-10 Finland
Other disorders of autonomic nervous system
+∞
43.2
41
*
AA1AD
NOMESCO Finland
CT of head and brain
3.5
42.1
243
912
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
10.0
38.3
79
88
H02.4
ICD-10 Finland
Ptosis of eyelid
11.8
34.2
64
59
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.2
32.5
107
232
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
8.5
30.7
69
89
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
28.4
361
2102
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.6
27.7
102
248
H57.0
ICD-10 Finland
Anomalies of pupillary function
28.2
26.0
35
13
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
97.1
25.8
28
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
7.8
23.4
55
76
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
23.0
22
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
14.2
23.0
39
29
N03AX16
ATC
pregabalin; oral
2.5
22.2
211
1021
G20
ICD-10 Finland
Parkinson disease
7.1
22.1
55
83
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
118.7
21.7
23
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
+∞
20.9
20
*
H02AA02
ATC
fludrocortisone; oral
19.0
20.6
31
17
TAB00
NOMESCO Finland
Lumbar puncture
5.2
18.1
57
117
R51.80
ICD-10 Finland
Headache
2.8
18.0
125
497
R55
ICD-10 Finland
Syncope and collapse
3.1
18.0
106
379
G44.0
ICD-10 Finland
Cluster headache syndrome
17.1
18.0
28
17
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
17.8
17
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.9
17.7
59
129
R53
ICD-10 Finland
Malaise and fatigue
2.4
17.5
173
841
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.5
17.1
85
268
XCK00
NOMESCO Finland
Perimetry
3.9
17.0
73
204
G90.1
ICD-10 Finland
Familial dysautonomia [Riley-Day]
+∞
16.7
16
*
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
28.3
16.6
22
8
I95.1
ICD-10 Finland
Orthostatic hypotension
6.6
16.3
42
67
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
15.7
15
*
R42
ICD-10 Finland
Dizziness and giddiness
2.3
15.6
168
847
N04BC05
ATC
pramipexole; oral
3.3
14.9
77
251
N87
ICPC
Parkinsonism
10.7
14.8
28
27
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.8
14.2
61
171
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.3
14.0
33
47
N03AX12
ATC
gabapentin; oral
2.4
13.9
124
567
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
5.0
13.5
43
90
Z3226
NOMESCO Finland
Physiotherapist
2.2
13.4
153
785
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.9
13.0
36
64
R4130
NOMESCO Finland
Speech therapy
7.2
13.0
31
45
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.1
13.0
73
252
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
12.5
12
*
G90.4
ICD-10 Finland
Autonomic dysreflexia
+∞
12.5
12
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.5
302
2057
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
12.5
66
219
N06AX21
ATC
duloxetine; oral
2.6
12.2
96
409
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
12.2
125
609
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
21.7
12.0
17
8
R4110
NOMESCO Finland
Physiotherapy
1.9
12.0
198
1175
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
11.9
208
1262
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
11.8
116
554
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
11.8
61
199
R13
ICD-10 Finland
Dysphagia
3.3
11.7
60
194
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
11.6
126
630
ZXD05
NOMESCO Finland
Urgent procedure
1.9
11.5
227
1432
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
11.5
11
*
XA800
NOMESCO Finland
Neuropsychological investigation
4.2
11.4
43
108
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
11.3
276
1865
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
6.1
11.3
30
51
N28
ICPC
Limited function/disability (N)
7.8
11.2
25
33
N04BD01
ATC
selegiline; oral
7.6
11.0
25
34
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.4
11.0
54
170
J01MA02
ATC
ciprofloxacin; systemic
1.8
10.7
271
1850
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
7.5
10.5
24
33
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
10.4
95
436
R06.0
ICD-10 Finland
Dyspnoea
1.9
10.3
177
1057
PA7BD
NOMESCO Finland
CT angiography of neck and brain
9.8
10.3
20
21
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
11.5
10.1
18
16
M03BX01
ATC
baclofen; systemic
7.4
10.0
23
32
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
9.7
75
316
A28
ICPC
Limited function/disability NOS
2.1
9.7
110
558
XF606
NOMESCO Finland
Ortostatic test
15.3
9.5
15
10
N06AX16
ATC
venlafaxine; oral
2.2
9.5
99
484
C08DA01
ATC
verapamil; systemic
3.7
9.5
40
112
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.1
9.4
50
167
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
+∞
9.4
9
*
3378X
ICD-9 Finland
Disorders of the autonomic nervous system[NEUROPATHIA AUTONOMICA PERIPHERICA ALIA DEFINITA]
+∞
9.4
9
*
PA6AD
NOMESCO Finland
CT of neck arteries
9.7
9.3
18
19
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.2
9.3
24
40
H02AB06
ATC
prednisolone; systemic
1.7
9.3
312
2284
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.2
119
638
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
9.2
65
260
R4120
NOMESCO Finland
Occupational therapy
2.9
9.2
57
210
N03AE01
ATC
clonazepam; systemic
2.9
9.2
54
194
N05AH04
ATC
quetiapine; oral
2.1
9.0
112
590
M03BX02
ATC
tizanidine; oral
1.6
8.9
407
3216
WX002
NOMESCO Finland
Sedation and analgesia
1.9
8.9
145
844
A02BC02
ATC
pantoprazole; systemic
1.6
8.9
433
3479
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.9
163
994
G93.3
ICD-10 Finland
Postviral fatigue syndrome
50.6
8.7
10
*
Z2445
NOMESCO Finland
Psychologist
3.7
8.7
37
105
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.4
8.7
40
121
A02BC05
ATC
esomeprazole; systemic
1.6
8.6
281
2025
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
8.6
146
864
R01AD08
ATC
fluticasone; nasal
1.8
8.6
190
1225
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
8.6
252
1766
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
8.6
127
717
N04BD02
ATC
rasagiline; oral
10.2
8.6
16
16
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
91.1
8.4
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
8.4
91
452
35800
ICD-8 Finland
Disease of peripheral autonomic nervous system, Syndroma Horner
+∞
8.3
8
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
8.3
8
*
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
+∞
8.3
8
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.0
8.3
32
83
B01AA03
ATC
warfarin; systemic
1.8
8.1
139
827
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
11.9
8.1
14
12
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
8.1
62
261
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
8.0
70
315
Z3231
NOMESCO Finland
Registered nurse
1.7
7.9
188
1239
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
7.9
214
1464
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
9.5
7.8
15
16
H02AB07
ATC
prednisone; oral
2.0
7.8
107
587
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
7.7
137
825
R52.2
ICD-10 Finland
Other chronic pain
3.8
7.6
31
85
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.6
7.6
25
56
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.6
177
1155
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.4
7.6
35
107
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
7.5
124
725
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.5
229
1611
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
7.4
75
361
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
7.4
259
1888
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
7.3
7
*
G23.3
ICD-10 Finland
Multiple system atrophy, cerebellar type [MSA-C]
+∞
7.3
7
*
N99
ICPC
Neurological disease other
6.3
7.3
18
29
N06AX11
ATC
mirtazapine; oral
1.6
7.3
207
1429
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
7.2
79
395
M79.6
ICD-10 Finland
Pain in limb
1.6
7.2
230
1635
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.3
7.2
67
311
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
7.2
251
1822
Q13.2
ICD-10 Finland
Other congenital malformations of iris
30.3
7.2
9
*
N04BC04
ATC
ropinirole; oral
6.7
7.1
17
26
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
7.1
94
505
N02BE01
ATC
paracetamol; systemic, rectal
1.7
7.1
578
5127
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.0
141
879
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
7.0
88
466
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
7.0
103
579
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
7.0
85
442
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
6.9
41
149
J01FA06
ATC
roxithromycin; oral
1.6
6.9
257
1891
B01AC07
ATC
dipyridamole; systemic
3.7
6.9
28
77
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
6.9
85
446
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.9
297
2261
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
6.9
78
395
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.1
6.8
20
40
ZXA00
NOMESCO Finland
Right side
1.6
6.8
181
1220
193
Kela drug reimbursment
Rasagiline
11.1
6.8
12
11
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.2
6.8
17
28
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
6.8
57
253
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
6.8
194
1335
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
16.9
6.8
10
6
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.5
6.7
29
85
R03AC02
ATC
salbutamol; inhalant
1.5
6.7
338
2662
B01AC04
ATC
clopidogrel; oral
2.0
6.7
87
468
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
6.6
65
308
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
6.6
188
1291
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
6.6
65
311
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.5
177
1202
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.1
6.5
19
38
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.2
6.5
67
326
L28
ICPC
Limited function/disability (L)
1.8
6.5
104
604
G99.2*M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
70.5
6.4
7
*
XX2CT
NOMESCO Finland
Other injection with CT guidance
70.5
6.4
7
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
7.5
6.4
14
19
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
6.4
49
208
Z2221
NOMESCO Finland
Medical doctor
1.6
6.3
187
1293
Z50.5
ICD-10 Finland
Speech therapy
5.6
6.3
17
31
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.6
6.3
20
44
G44.2
ICD-10 Finland
Tension-type headache
2.0
6.3
84
453
N06AB04
ATC
citalopram; systemic
1.7
6.3
139
890
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
9.4
6.3
12
13
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.4
6.3
12
13
N17
ICPC
Vertigo/dizziness
2.0
6.3
74
382
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.9
6.3
19
40
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
G93.0
ICD-10 Finland
Cerebral cysts
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
1.9
6.2
93
525
N18
ICPC
Paralysis/weakness
5.1
6.2
18
36
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
6.2
47
198
Z2446
NOMESCO Finland
Social worker
2.4
6.1
52
230
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.8
6.1
13
17
H53.1
ICD-10 Finland
Subjective visual disturbances
2.5
6.1
44
181
ZXA05
NOMESCO Finland
Left side
1.6
6.1
167
1131
N29
ICPC
Neurological sympt/complt other
5.0
6.1
18
37
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
6.1
47
201
Z73.6
ICD-10 Finland
Limitation of activities due to disability
8.7
6.1
12
14
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
6.8
6.1
14
21
ZXE00
NOMESCO Finland
One hour or less
1.5
6.0
263
1994
N03AX11
ATC
topiramate; oral
3.6
6.0
25
71
A02BC03
ATC
lansoprazole; oral
1.6
6.0
184
1283
N02AA05
ATC
oxycodone; systemic
1.8
6.0
95
548
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.6
6.0
19
42
ZXA10
NOMESCO Finland
Bilateral
1.7
6.0
127
801
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
340
1801
2.54
35.22
2.6
2.1
u/l
216.1
275.5
0.43
317
1687
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
426
2838
2.07
22.30
7.2
5.9
mmol/l
1.2
1.2
1.05
390
2568
(3018677) aPTT in Platelet poor plasma by Coagulation assay
185
898
2.38
21.57
2.0
1.9
s
29.6
29.7
0.07
180
865
(3036481) Cortisol [Moles/volume] in Serum or Plasma
133
564
2.63
20.65
2.4
1.9
nmol/l
401.2
380.4
0.41
123
522
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
450
3114
2.02
20.58
8.3
6.5
mmol/l
1.2
1.2
0.13
381
2637
(3032080) INR in Blood by Coagulation assay
378
2508
1.96
19.01
8.4
9.0
inr
1.2
1.2
0.04
96
722
(3013826) Glucose [Moles/volume] in Serum or Plasma
505
3706
1.98
18.75
5.9
4.6
mmol/l
6.6
6.7
0.36
481
3454
(3018418) pH of Serum or Plasma
304
1880
1.99
18.68
4.5
3.8
ph
7.4
7.4
2.19
62
344
(3002030) Lymphocytes/100 leukocytes in Blood
437
3096
1.91
17.55
7.2
5.9
%
27.0
27.9
0.93
413
2888
(3001604) Monocytes [#/volume] in Blood
446
3183
1.91
17.49
7.0
5.6
e9/l
0.6
0.6
0.25
391
2749
(3019198) Lymphocytes [#/volume] in Blood
455
3273
1.90
17.37
7.0
5.6
e9/l
1.8
1.9
0.97
411
2894
(3013115) Eosinophils [#/volume] in Blood
459
3317
1.90
17.21
7.3
5.9
e9/l
0.2
0.2
0.57
416
2918
(42870588) Differential panel, method unspecified - Blood
328
2129
1.92
17.12
6.6
5.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
446
3198
1.89
17.08
7.0
5.6
e9/l
0.0
0.0
0.12
396
2768
(3019069) Monocytes/100 leukocytes in Blood
426
3018
1.88
16.86
7.3
6.0
%
8.7
8.7
0.11
404
2830
(3006504) Eosinophils/100 leukocytes in Blood
424
3003
1.88
16.76
7.0
5.8
%
2.9
2.8
0.07
402
2791
(3022096) Basophils/100 leukocytes in Blood
414
2916
1.87
16.60
7.1
5.8
%
0.6
0.7
1.40
395
2722
(3018010) Neutrophils/100 leukocytes in Blood
429
3060
1.87
16.48
7.1
5.6
%
57.8
57.2
0.46
408
2877
(3024561) Albumin [Mass/volume] in Serum or Plasma
386
2665
1.87
16.43
5.7
4.7
g/l
35.3
35.6
0.64
358
2471
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
29
50
5.98
16.28
1.1
1.1
nmol/l
0.5
1.9
—
6
8
(3023368) Bacteria identified in Blood by Culture
275
1709
1.93
16.17
4.3
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
159
829
2.15
15.14
1.5
1.3
titre
593.8
412.2
0.38
32
174
(3004789) Transferrin [Mass/volume] in Serum or Plasma
167
889
2.11
15.06
2.7
2.3
g/l
2.4
2.3
0.15
161
823
(40758558) Short blood count panel - Blood
253
1581
1.88
14.31
7.5
6.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
488
3716
1.80
14.26
10.0
9.1
e9/l
4.4
4.1
0.87
440
3253
(3007853) Bacteria identified in Skin by Aerobe culture
144
742
2.15
14.06
1.9
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
155
826
2.09
13.85
2.9
2.4
%
23.3
23.0
0.08
139
705
(3022948) Iron [Moles/volume] in Serum or Plasma
172
961
2.01
13.47
2.9
2.3
umol/l
13.0
13.2
0.15
167
885
(3013707) Erythrocyte sedimentation rate by Westergren method
583
4727
1.86
13.38
5.3
4.0
mm/h
12.0
12.3
0.13
556
4335
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
50
5.34
13.03
1.1
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
328
2272
1.75
12.88
4.2
3.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
103
3.82
12.51
1.4
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
364
2618
1.72
12.34
2.6
2.2
nmol/l
79.8
76.6
1.36
331
2332
(36304419) Bacteria [Presence] in Urine
263
1730
1.77
12.23
3.9
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
173
1003
1.92
12.05
4.0
3.2
mmol/l
0.8
0.8
0.00
165
941
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
193
1168
1.86
11.75
4.4
3.6
ng/l
66.2
312.5
3.56
149
901
(3030467) Casts [#/volume] in Urine by Automated count
266
1779
1.74
11.55
4.0
3.0
e6/l
0.4
0.4
0.19
200
1342
(3001122) Ferritin [Mass/volume] in Serum or Plasma
374
2750
1.68
11.39
3.5
2.7
ug/l
124.1
137.2
0.32
350
2527
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
38
111
3.54
11.24
1.4
1.1
e6/l
41.9
7.7
0.54
29
80
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
38
111
3.54
11.24
1.4
1.2
e6/l
1474.1
1208.0
0.07
30
83
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
66
268
2.59
11.04
1.7
2.1
u/l
34.3
38.6
0.92
61
241
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
39
118
3.42
10.94
1.3
1.1
mmol/l
3.7
3.7
0.01
34
108
(3018095) Leukocytes [#/volume] in Urine
321
2287
1.67
10.89
4.7
3.6
e6/l
62.9
87.8
0.45
228
1608
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
27
63
4.40
10.83
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
40
124
3.34
10.81
2.8
3.3
umol/l
30.8
33.5
0.30
34
105
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
26
59
4.52
10.79
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
280
1930
1.69
10.74
4.1
3.1
e6/l
22.3
117.6
2.02
216
1480
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
80
361
2.35
10.67
4.8
3.2
pmol/l
4.6
4.6
0.01
70
312
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
587
4908
1.73
10.54
9.2
7.5
u/l
79.4
78.5
0.15
554
4578
(3019309) Folate [Moles/volume] in Red Blood Cells
184
1132
1.81
10.50
1.8
1.7
nmol/l
1123.3
1184.5
0.43
149
841
(3005719) IgG [Mass/volume] in Serum or Plasma
96
472
2.17
10.44
3.5
2.5
g/l
9.7
10.7
1.78
86
434
(3000850) Epithelial cells [#/volume] in Urine
206
1323
1.75
10.12
3.2
2.5
e6/l
5.1
5.9
0.36
175
1165
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
349
2575
1.63
10.12
2.4
1.9
pmol/l
95.8
95.1
0.11
188
1324
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
69
299
2.43
10.07
3.8
4.2
mmol/l
24.9
24.1
1.44
64
266
(3003396) Base excess in Arterial blood by calculation
125
692
1.96
9.86
7.2
7.8
mmol/l
1.3
1.3
0.01
100
545
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
175
1079
1.80
9.86
3.0
2.7
e6/l
0.9
0.9
0.02
110
615
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
232
1560
1.69
9.57
2.6
2.0
mg/l
2.9
3.1
0.39
206
1315
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
323
2371
1.61
9.36
4.1
3.5
ng/l
25.2
41.4
2.69
216
1643
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
30
5.77
9.31
1.1
1.0
u/l
1.1
1.0
—
9
20
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
108
580
2.00
9.27
2.7
2.3
u/l
30.1
39.9
0.61
95
491
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
226
1520
1.68
9.27
2.4
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
162
995
1.79
9.19
2.0
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
423
3325
1.58
9.05
6.8
6.3
umol/l
11.5
11.5
0.00
397
3150
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
35
5.24
8.91
2.2
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
39
4.97
8.87
1.1
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
220
1485
1.66
8.84
1.7
1.5
nmol/l
20.0
20.7
0.33
198
1252
(3015377) Calcium [Moles/volume] in Serum or Plasma
293
2125
1.60
8.80
3.3
3.4
mmol/l
2.3
2.4
1.31
252
1850
(3011412) CD3 cells [#/volume] in Blood
22
52
4.32
8.70
2.9
2.0
e9/l
1.3
1.2
0.15
15
26
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
13
8.57
8.48
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
162
1024
1.73
8.25
3.5
2.9
e6/l
4.8
2.2
1.20
96
560
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
121
702
1.85
8.22
1.9
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
120
697
1.85
8.12
1.9
1.8
—
—
—
0
0
(4062490)
21
51
4.20
8.03
1.4
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
65
3.78
7.95
1.3
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
67
320
2.19
7.83
8.3
9.4
mmol/l
24.8
24.5
0.30
62
298
(3044640) Blood type and Crossmatch panel - Blood
276
2017
1.56
7.83
2.6
2.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
569
4876
1.58
7.68
4.9
3.8
pmol/l
14.9
14.8
0.28
531
4402
(3031040) Bacteria [#/volume] in Urine by Automated count
503
4196
1.53
7.66
6.4
4.3
e6/l
1854.6
2999.8
—
8
64
(40767503) Oxygen content in Capillary blood by calculation
37
135
2.83
7.64
1.9
2.6
%
17.4
16.2
1.13
21
73
(3026782) Osmolality of Urine
188
1262
1.64
7.58
3.6
2.7
mosm/kgh2o
552.0
557.6
0.12
153
1081
(3016018) Differential panel - Cerebral spinal fluid
20
49
4.16
7.57
1.4
1.1
—
—
—
0
0
(3036489) Thrombin time
50
214
2.43
7.53
2.2
1.8
s
22.9
21.2
0.90
50
190
(3000991) Gas panel - Venous blood
92
502
1.94
7.52
8.6
8.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
41
4.47
7.46
1.3
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
37
4.67
7.43
2.3
1.9
%
9.8
12.3
—
9
20
(3037467) Urinalysis macro (dipstick) panel - Urine
524
4428
1.53
7.36
5.6
4.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
75
384
2.05
7.34
2.0
1.7
g/l
1.3
1.6
0.94
65
354
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
658
5868
1.68
7.25
5.9
4.5
mu/l
1.9
2.1
0.32
615
5330
(3021589) Normoblasts [#/volume] in Blood
365
2869
1.50
7.23
11.2
9.2
e9/l
0.0
0.0
0.53
299
2335
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
206
1430
1.59
7.20
2.0
1.6
mg/l
2.1
1.1
0.49
152
1097
(3052851) Hemolysis interference index of Serum or Plasma
44
183
2.49
7.05
2.7
3.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
119
2.85
6.98
1.4
1.2
u/ml
246.3
254.8
0.05
24
69
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
48
209
2.38
6.97
1.7
2.3
ug/l
142.1
446.5
1.46
43
201
(4027681)
16
35
4.64
6.95
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
136
861
1.70
6.81
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
268
1996
1.51
6.77
2.8
2.5
u/l
52.7
56.2
0.91
245
1836
(3002032) Base excess in Venous blood by calculation
100
581
1.82
6.74
4.1
3.8
mmol/l
2.2
1.9
0.52
87
462
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
99
576
1.82
6.64
2.8
2.2
g/l
0.2
0.2
0.54
92
535
(3020779) Urea [Moles/volume] in Serum or Plasma
91
518
1.85
6.55
7.1
7.3
mmol/l
7.7
9.5
2.10
86
492
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
107
2.87
6.48
1.9
1.5
u/ml
98.8
110.9
—
6
19
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
80
439
1.91
6.44
1.3
1.2
iu/ml
132.1
151.6
0.12
29
176
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
126
2.69
6.29
1.4
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
702
6442
1.73
6.07
21.2
13.6
mg/l
22.6
24.1
0.55
594
5051
(3019550) Sodium [Moles/volume] in Serum or Plasma
718
6632
1.80
6.05
22.6
15.5
mmol/l
139.6
139.7
0.46
703
6437
(3005322) IgE [Units/volume] in Serum or Plasma
73
397
1.92
6.04
1.3
1.3
u/ml
96.9
201.5
2.47
65
364
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
68
3.30
6.04
1.5
1.3
nmol/l
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
719
6646
1.80
6.01
22.8
15.7
mmol/l
4.0
4.0
1.24
703
6443
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
16
6.32
5.96
1.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
61
313
2.03
5.95
8.2
10.9
—
—
—
0
0
(3009343) pH of Capillary blood
78
436
1.87
5.94
4.2
4.0
ph
7.4
7.4
1.28
14
53
(3020630) Protein [Mass/volume] in Serum or Plasma
86
496
1.82
5.94
2.7
2.9
g/l
65.4
67.0
1.16
76
454
(3026008) Bacteria identified in Urine by Culture
249
1871
1.48
5.88
4.1
3.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
119
2.67
5.87
1.9
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
75
416
1.89
5.85
4.3
4.0
mmol/l
1.9
1.9
0.00
60
318
(3007164) IgA [Mass/volume] in Serum or Plasma
180
1269
1.54
5.75
1.8
1.4
g/l
2.1
2.5
1.54
111
774
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
268
2051
1.46
5.73
3.6
3.3
u/l
41.8
32.4
1.12
258
1946
(3026493) Urate [Moles/volume] in Serum or Plasma
224
1655
1.49
5.73
3.0
2.5
umol/l
3547.7
7314.2
0.81
188
1442
(3003458) Phosphate [Moles/volume] in Serum or Plasma
126
820
1.64
5.65
7.2
5.4
mmol/l
1.0
1.0
0.01
121
756
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
151
1029
1.58
5.59
1.4
1.3
u/ml
2.7
10.7
3.59
49
410
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
68
372
1.90
5.54
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
164
1144
1.55
5.47
3.0
3.1
mmol/l
2.5
2.4
0.19
144
1000
(3012501) Base excess in Blood by calculation
32
130
2.52
5.43
2.2
3.2
mmol/l
2.7
2.5
0.13
22
90
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
157
1087
1.55
5.42
1.4
1.3
iu/ml
44.3
36.4
0.17
49
334
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
241
1825
1.46
5.39
2.8
2.9
ng/l
872.5
1279.4
1.55
207
1546
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
169
2.31
5.31
1.7
1.4
u/l
11.4
8.2
0.52
27
139
(3015235) Bicarbonate [Moles/volume] in Capillary blood
38
169
2.31
5.31
3.0
3.1
mmol/l
25.3
25.3
0.01
38
148
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
195
1426
1.49
5.18
1.4
1.3
u/ml
7.5
1.8
1.02
55
364
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
92
2.77
5.14
1.4
1.9
g/l
0.6
0.9
0.43
19
72
(3027945) Reticulocytes/100 erythrocytes in Blood
107
686
1.65
5.08
3.3
2.6
%
1.8
1.8
0.06
99
621
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
19
5.32
5.05
1.1
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
19
5.32
5.05
1.1
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
19
5.32
5.05
1.1
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
19
5.32
5.05
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
100
631
1.67
5.05
3.8
3.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
194
2.17
4.97
1.9
2.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
22
77
2.91
4.96
1.5
1.3
nmol/l
0.5
0.6
0.98
22
70
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
81
488
1.73
4.84
2.5
2.9
ng/l
167.7
206.3
0.27
72
446
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
68
2.99
4.74
1.3
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
195
1449
1.46
4.74
4.0
3.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
39
185
2.16
4.71
2.3
2.1
%
89.8
90.3
0.04
39
177
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
74
2.89
4.68
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
32
140
2.34
4.67
2.2
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
29
4.19
4.64
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
376
3140
1.37
4.63
4.5
3.5
estimate
0.0
0.0
0.00
69
594
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
64
3.02
4.58
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
67
391
1.78
4.48
5.0
5.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
72
430
1.74
4.45
1.7
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
378
3177
1.36
4.39
4.5
3.6
estimate
0.0
0.0
0.50
70
579
(3028626) Oxygen [Partial pressure] in Capillary blood
37
179
2.12
4.27
3.8
4.4
kpa
8.7
8.2
0.99
37
168
(3023410) Appearance of Cerebral spinal fluid
17
56
3.08
4.26
1.5
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
115
783
1.55
4.25
2.4
2.3
ug/g
105.9
121.3
0.26
89
618
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
109
739
1.55
4.10
3.9
2.7
umol/l
10.5
7.9
0.48
94
645
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
174
1300
1.43
4.06
1.8
1.7
pmol/l
429.3
22514495.4
1.32
145
1066
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
28
3.97
3.99
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
154
1131
1.45
3.93
2.1
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
482
4245
1.34
3.92
3.9
3.1
u/l
48.6
48.7
0.01
443
3955
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
355
2991
1.34
3.91
4.1
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
370
3140
1.33
3.87
6.1
4.9
estimate
0.0
0.0
0.50
71
603
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
29
3.83
3.81
1.6
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
29
3.83
3.81
1.8
2.5
u/ml
460.6
710.6
0.79
11
29
(3021901) Oxygen saturation in Capillary blood
28
127
2.25
3.80
2.2
2.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
75
475
1.64
3.76
1.5
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
129
924
1.47
3.74
2.2
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
29
136
2.17
3.65
2.4
3.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
30
3.70
3.65
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
35
3.47
3.63
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
206
1.94
3.59
1.5
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
9
7.83
3.56
1.1
1.0
mg/g
10.5
6.5
—
7
9
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
93
2.40
3.51
1.3
1.2
u/ml
4.8
6.7
0.25
11
39
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
208
1.92
3.50
2.1
2.4
g/l
2.9
3.1
1.15
26
169
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
87
2.45
3.49
1.3
1.2
u/ml
1.5
2.5
—
10
24
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
31
3.58
3.49
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
175
1.98
3.38
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
54
323
1.72
3.37
4.6
4.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
10
7.05
3.37
1.1
1.0
—
—
—
0
0
(4010399)
70
449
1.61
3.35
1.4
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
34
176
1.97
3.33
1.6
1.7
iu/l
9.4
5.8
0.44
12
50
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
60
372
1.66
3.29
1.6
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
27
129
2.13
3.27
3.4
2.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
84
2.42
3.25
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
64
406
1.63
3.21
2.6
2.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
15
5.38
3.19
2.6
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
11
6.41
3.19
2.6
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
23
104
2.25
3.18
1.2
1.3
mmol/l
82.3
65.6
0.70
18
90
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
223
1.84
3.16
2.1
2.3
g/l
4.0
3.8
0.33
25
166
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
223
1.84
3.16
2.1
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
223
1.84
3.16
2.1
2.3
g/l
6.8
7.4
1.06
26
173
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
505
1.56
3.15
2.4
2.4
ug/l
5.8
6.8
0.24
61
444
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
32
166
1.97
3.13
1.8
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
224
1.83
3.12
1.6
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
195
1.89
3.11
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
224
1815
1.33
3.09
3.2
3.3
mg/l
653.6
184.7
0.56
142
1171
(4094501)
33
174
1.94
3.09
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
16
5.04
3.05
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
45
2.92
3.03
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
12
5.87
3.02
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
198
1.86
2.98
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
57
2.66
2.98
9.3
5.0
u/ml
82.0
52.3
—
7
16
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
76
512
1.54
2.97
3.4
3.6
mmol/l
1.2
1.2
0.90
70
440
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
199
1.85
2.94
1.7
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
30
3.36
2.91
1.2
1.4
nmol/l
168.1
161.9
—
10
30
(3025941) Bacteria identified in Stool by Culture
57
361
1.62
2.90
1.4
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
9
6.71
2.87
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
172
1.90
2.85
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
562
0.55
2.83
1.7
1.7
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
18
4.48
2.80
1.1
2.8
ug/l
1.5
1.5
—
8
18
(3017143) Hepatitis C virus Ab [Presence] in Serum
100
722
1.44
2.80
1.8
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
210
1.80
2.79
2.2
2.3
g/l
9.9
10.7
0.42
25
183
(3028717) Thiamine [Mass/volume] in Blood
5
6
8.38
2.75
1.6
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
646
6064
1.34
2.69
18.3
12.7
ml/min/173m2
85.2
81.6
4.17
567
4967
(3023323) Follitropin [Units/volume] in Serum or Plasma
44
266
1.69
2.69
1.6
1.3
iu/l
19.7
26.1
0.90
36
228
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
19
4.24
2.68
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
708
6745
1.43
2.68
18.2
12.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
296
2531
1.27
2.65
2.2
2.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
33
184
1.83
2.65
2.3
2.3
g/l
36.5
37.8
0.45
25
159
(3011288) Drugs identified in Urine by Screen method
31
170
1.86
2.62
2.5
2.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
237
1978
1.28
2.57
3.1
3.2
mmol/l
7.8
7.7
0.06
193
1647
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
18
81
2.25
2.55
1.0
1.1
%
109.8
117.5
0.40
18
74
(3026389) Candida sp identified in Specimen by Organism specific culture
18
81
2.25
2.55
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
34
194
1.79
2.54
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
50
2.63
2.54
2.8
2.2
e6/l
697.5
619.5
—
6
19
(36660697) Celiac disease serology panel - Serum
72
499
1.49
2.50
1.2
1.2
—
—
—
0
0
(4306422)
18
82
2.22
2.49
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
176
1419
1.31
2.48
4.9
4.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
191
2308
0.77
2.47
2.9
2.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
116
2.01
2.47
1.6
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
182
1.79
2.43
1.4
1.4
ug/g
333.7
300.8
0.27
14
107
(3051611) Lipemic interference index of Serum or Plasma
16
70
2.31
2.42
2.8
3.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
205
1.74
2.41
2.1
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
90
2.14
2.40
3.1
3.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
8
6.28
2.37
1.0
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
8
6.28
2.37
1.4
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.66
2.37
1.1
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
72
506
1.46
2.34
2.8
2.6
e9/l
74.0
70.8
0.27
53
388
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
31
177
1.78
2.33
2.4
2.5
g/l
0.0
0.0
0.50
25
163
(3022145) Colonoscopy Study observation
99
739
1.39
2.32
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
51
334
1.56
2.30
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
104
786
1.37
2.26
1.9
1.8
%
1.7
1.5
1.15
90
702
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
33
194
1.73
2.26
2.3
2.6
g/l
0.2
1.2
1.99
25
173
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
86
2.12
2.24
1.8
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
128
1.90
2.23
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
121
1.93
2.22
1.4
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
100
2.03
2.22
1.7
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
24
3.36
2.18
1.1
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
491
4506
1.23
2.17
4.2
3.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
227
1920
1.25
2.16
4.1
4.0
mg/mmol
13.5
7.8
0.63
139
1229
(3011985) Renin [Units/volume] in Plasma
16
74
2.19
2.16
1.5
1.4
mu/l
64.2
47.4
0.20
16
68
(3028433) Virus identified in Specimen by Culture
9
30
3.02
2.15
1.2
1.6
—
—
—
0
0
(4035726)
75
541
1.43
2.14
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
175
1.74
2.12
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
37
2.72
2.11
2.9
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
124
1.88
2.09
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
124
1.88
2.09
1.6
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
31
2.92
2.07
1.8
3.2
nmol/l
269.1
80.5
—
9
31
(3008401) Mugwort IgE Ab [Units/volume] in Serum
20
103
1.97
2.07
1.1
1.1
u/ml
0.8
1.7
—
9
42
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
29
169
1.74
2.06
2.4
2.4
g/l
0.0
0.0
0.00
23
155
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
177
1.72
2.05
3.1
2.7
u/ml
0.3
0.3
0.02
16
95
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
67
479
1.44
2.02
4.5
3.6
ng/l
74.2
81.5
0.29
62
419
(4268621)
14
63
2.24
2.02
2.8
2.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
32
2.83
2.00
13.4
8.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
43
281
1.56
1.99
5.2
4.4
mmol/l
24.9
25.0
0.11
43
267
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
398
0.57
1.99
1.7
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
77
2.10
1.97
1.4
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
584
5484
1.24
1.97
26.2
17.5
g/l
332.0
332.6
0.92
578
5433
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
21
3.35
1.97
1.6
2.1
ug/l
108.6
81.2
—
7
21
(3000494) Fungus identified in Specimen by Culture
103
797
1.34
1.94
1.6
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
16
3.77
1.93
5.5
4.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
45
2.46
1.93
3.3
1.8
%
9.8
10.6
0.20
11
45
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
39
2.58
1.92
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
65
2.17
1.89
1.1
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
22
3.20
1.88
1.0
1.0
miu/ml
1299.3
1698.4
—
7
22
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
72
2.10
1.87
1.1
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
9
34
2.67
1.87
1.2
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
28
167
1.70
1.86
2.5
2.4
g/l
0.0
0.0
0.00
23
154
(3020891) Body temperature
35
222
1.60
1.85
5.0
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
69
505
1.40
1.85
4.8
3.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
17
3.55
1.84
1.0
1.2
—
—
—
0
0
(3013512) EKG study
219
1876
1.23
1.83
4.2
3.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
108
1.87
1.83
1.1
1.0
u/ml
5.3
9.0
0.63
13
55
(3006462) Nitrate [Presence] in Urine
7
23
3.06
1.80
2.7
3.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
20
109
1.86
1.78
1.8
1.2
—
—
—
0
0
(3019225) pH of Specimen
80
605
1.36
1.77
5.3
4.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
67
2.11
1.76
1.2
2.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
209
1.60
1.76
1.5
1.6
iu/ml
0.3
29.4
—
6
41
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
30
2.68
1.72
2.4
2.3
%
93.6
107.9
—
8
30
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
13
3.86
1.71
3.2
2.1
umol/l
22.0
15.5
—
5
13
(3051651) Icteric interference index of Serum or Plasma
11
48
2.31
1.71
1.7
3.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
931
1.29
1.70
1.8
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
266
0.52
1.69
1.4
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
19
3.17
1.66
4.7
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
19
3.17
1.66
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
142
1.71
1.66
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
112
1.81
1.65
1.4
1.8
—
—
—
0
0
(4211845)
7
25
2.82
1.65
2.7
3.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
105
1.83
1.64
1.2
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
5
14
3.59
1.61
1.4
1.1
mmol/l
1.3
2.4
—
5
14
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
159
1.66
1.60
1.5
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
98
776
1.30
1.60
8.8
6.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
70
2.02
1.60
2.3
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
223
1.55
1.59
1.7
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
99
1.84
1.58
1.1
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
26
2.71
1.58
3.6
5.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
160
1.65
1.57
1.6
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
573
5418
1.20
1.57
25.2
16.6
%
13.7
13.7
0.06
567
5305
(3000492) Spirometry study
80
618
1.33
1.56
1.6
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
15
3.35
1.52
1.2
1.1
%
118.0
93.3
—
5
15
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
93
1.85
1.52
1.8
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
93
1.85
1.52
1.6
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
123
1.73
1.52
1.1
1.1
u/ml
0.7
1.3
—
10
48
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
108
1.78
1.51
1.8
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
6
21
2.87
1.51
1.2
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
40
277
1.47
1.47
2.0
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
45
2.24
1.47
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
65
493
1.35
1.44
3.4
4.4
%
0.1
0.8
0.60
18
133
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
154
0.45
1.44
1.1
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
16
3.14
1.44
1.6
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
164
1399
1.22
1.42
5.2
3.8
kg/l
1.0
1.0
0.10
26
187
(3022217) INR in Platelet poor plasma by Coagulation assay
97
781
1.28
1.41
21.0
23.6
inr
1.2
1.3
—
8
111
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
40
2.26
1.40
2.1
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
150
1.62
1.39
1.3
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
223
1.50
1.38
2.5
2.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
21
127
1.67
1.37
1.5
1.2
u/ml
28.7
14.3
—
5
9
(3037756) Immunofixation for Serum or Plasma
21
127
1.67
1.37
1.4
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
23
2.62
1.37
1.8
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
23
2.62
1.37
1.8
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
272
2438
1.18
1.36
5.1
3.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
71
553
1.31
1.33
3.2
4.2
%
1.0
1.0
0.06
24
176
(40761536) Microorganisms panel - Urine sediment
71
553
1.31
1.33
5.2
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
133
1119
1.23
1.32
1.6
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
24
2.51
1.30
2.8
2.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
62
476
1.33
1.29
2.6
2.2
nmol/l
17.0
12.8
0.76
55
426
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
18
2.79
1.28
1.4
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
2.0
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
99
1.73
1.28
1.1
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
15
84
1.80
1.27
9.5
6.1
mg/l
11.5
11.2
0.12
15
77
(3019832) Treponema pallidum Ab [Presence] in Serum
71
557
1.30
1.27
1.6
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
329
1.39
1.27
1.5
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
25
162
1.56
1.27
1.6
1.2
u/ml
1.4
6.3
—
5
24
(3009542) Hematocrit [Volume Fraction] of Blood
622
5966
1.19
1.27
23.0
14.5
%
39.1
39.9
1.37
448
4306
(3045414) Leukocytes [Presence] in Urine
37
263
1.43
1.23
1.9
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
116
1.65
1.22
1.6
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
37
2.17
1.21
1.4
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
37
2.17
1.21
1.4
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
37
2.17
1.21
1.6
1.3
ug/l
4.0
6.0
—
8
31
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
64
1.89
1.18
2.4
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
198
1.48
1.18
1.4
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
57
1.94
1.17
1.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
20
2.51
1.15
2.2
16.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
20
2.51
1.15
1.2
2.2
%
146.2
133.0
—
5
20
(3029937) Albumin [Presence] in Urine by Test strip
192
1696
1.17
1.14
5.5
3.8
estimate
0.0
0.0
0.50
69
588
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
51
1.97
1.11
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
51
1.97
1.11
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
51
1.97
1.11
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
51
1.97
1.11
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
96
1.68
1.10
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
66
524
1.28
1.10
3.3
4.3
%
0.0
0.1
0.90
20
159
(3004451) EKG impression Narrative
7
31
2.27
1.10
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
2.4
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
89
1.70
1.08
1.0
1.0
u/ml
0.5
5.0
—
7
30
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
62
490
1.29
1.08
3.0
2.8
ml/min/173m2
64.1
66.5
0.21
26
205
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
122
0.49
1.06
1.2
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
412
1.31
1.05
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
196
1.44
1.03
1.7
2.2
u/l
3312.7
1724.5
—
5
68
(3045424) Erythrocytes [Presence] in Urine
17
106
1.62
1.03
1.6
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
2.6
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
195
1739
1.16
1.03
4.3
3.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
155
1.50
1.02
1.2
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
10
53
1.90
1.01
1.2
1.8
mmol/l
7.3
6.7
—
10
32
(3015076) Soybean IgE Ab [Units/volume] in Serum
7
35
2.01
1.00
1.1
1.1
u/ml
—
0.2
—
0
6
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
35
2.01
1.00
2.6
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
35
2.01
1.00
1.3
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
240
1.39
1.00
2.0
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
49
1.85
0.99
1.6
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
54
1.86
0.97
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
69
1.75
0.97
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.97
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
50
1.81
0.97
1.6
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.97
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.97
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
356
1.31
0.95
2.3
1.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
20
133
1.52
0.95
8.6
9.8
mmol/l
104.6
105.5
0.30
20
120
(3039000) Anion gap in Blood
20
133
1.52
0.95
8.5
9.8
mmol/l
12.8
11.4
0.37
20
120
(40768795) Lymph node Pathology biopsy report
9
51
1.77
0.94
1.6
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
118
0.50
0.94
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
118
0.50
0.94
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
144
0.55
0.94
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
144
0.55
0.94
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
144
0.55
0.94
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
144
0.55
0.94
1.1
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
70
1.73
0.93
2.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
126
1.52
0.92
1.8
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
51
403
1.28
0.91
3.1
2.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
110
1.56
0.91
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
185
1.42
0.90
1.1
1.1
u/ml
20.0
5.9
—
5
20
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
431
4078
1.12
0.90
3.5
3.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
79
659
1.22
0.90
3.1
4.4
ug/l
2.9
25.3
1.18
61
545
(3016879) Cocaine [Presence] in Urine
32
237
1.36
0.89
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.8
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
34
255
1.35
0.88
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
43
1.87
0.87
1.5
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
8
43
1.87
0.87
1.6
1.4
u/l
9.1
14.1
—
8
38
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
610
5900
1.14
0.87
6.2
5.7
mmol/mol
40.0
39.7
0.31
572
5453
(3012441) Differential panel - Pleural fluid
11
64
1.73
0.86
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
61
498
1.24
0.85
3.3
4.1
%
0.3
0.6
0.57
15
126
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
104
1.55
0.85
2.3
3.0
—
—
—
0
0
(44790049)
13
80
1.64
0.85
1.2
1.6
—
—
—
0
0
(44790048)
13
80
1.64
0.85
1.2
1.6
—
—
—
0
0
(44806118)
13
80
1.64
0.85
1.2
1.6
—
—
—
0
0
(44790047)
13
80
1.64
0.85
1.2
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
121
1.50
0.83
2.9
3.9
%
58.3
57.2
0.15
18
121
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
46
1.75
0.82
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
12
73
1.65
0.82
1.7
1.5
ug/l
19.5
16.9
0.19
12
73
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
94
806
1.19
0.82
1.4
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
89
1.58
0.81
2.6
2.8
u/ml
3.5
47.7
0.50
14
84
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
705
6899
1.18
0.81
13.5
10.1
u/l
26.5
26.5
0.00
681
6635
(3000764) Benzodiazepines [Presence] in Urine
33
250
1.33
0.81
1.8
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
47
1.71
0.81
5.5
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
33
251
1.33
0.79
1.8
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
66
1.68
0.79
1.3
1.2
e6/l
38827.8
42663.2
—
6
41
(3029075) Extractable nuclear Ab panel - Serum
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
253
1.32
0.76
1.8
1.7
—
—
—
0
0
(4024509)
9
53
1.71
0.75
1.9
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
231
2130
1.12
0.73
4.3
4.8
ug/l
2.3
3.0
0.82
202
1894
(3045788) Cell count panel - Pleural fluid
9
55
1.64
0.73
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
40
317
1.28
0.73
1.4
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
92
1.53
0.72
2.6
2.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
56
1.61
0.72
1.8
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
117
1.46
0.72
2.7
3.5
e9/l
4.0
4.3
0.35
17
117
(40768793) Breast Pathology biopsy report
10
158
0.63
0.71
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
58
1.56
0.70
5.2
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
93
1.51
0.70
1.1
1.0
u/ml
1.6
1.7
—
7
37
(3014051) Protein [Presence] in Urine by Test strip
19
135
1.42
0.69
2.2
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
144
1.40
0.68
5.0
4.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
23
170
1.36
0.68
1.1
1.2
—
653.3
—
0
6
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
102
1.48
0.68
2.4
3.5
—
710.6
—
0
9
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
92
0.54
0.67
1.6
1.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
1.2
1.3
g/l
0.3
0.3
—
5
23
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
163
1.36
0.65
1.5
2.3
ug/min
84.4
91.8
0.05
15
89
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
619
6339
0.90
0.63
4.9
4.3
mmol/l
1.4
1.5
0.36
563
5819
(3023199) Leukocytes [#/volume] in Pleural fluid
11
71
1.56
0.62
1.3
1.2
e6/l
2644.7
1321.5
—
6
50
(3027944) Amphetamines [Presence] in Urine
32
253
1.28
0.62
1.8
1.7
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
21
0.00
0.60
0.0
1.3
—
15.8
—
0
14
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
8
52
1.54
0.59
1.3
1.2
—
77.8
—
0
5
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
332
0.78
0.59
4.5
3.0
u/ml
19.2
61.5
1.89
26
320
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
175
1.32
0.58
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
184
1702
1.11
0.56
3.8
4.1
%
23.7
21.3
1.11
82
799
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
807
1.14
0.56
5.1
4.3
%
32.6
31.7
0.35
68
527
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
82
1.47
0.54
1.0
1.0
u/ml
1.5
7.3
—
6
28
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
72
630
1.16
0.53
2.5
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
108
1.40
0.53
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
638
6246
1.11
0.53
4.8
4.4
mmol/l
5.9
5.9
0.05
586
5674
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
106
954
1.13
0.53
1.4
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
636
6485
0.91
0.51
5.4
4.8
mmol/l
2.7
2.8
1.26
584
5949
(3016750) Collection duration of Urine
6
41
1.47
0.50
1.5
2.4
min
537.5
501.6
—
6
25
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
46
1.53
0.48
1.1
1.0
mg/l
331.0
275.7
—
7
39
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
76
1.45
0.48
1.5
4.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
78
695
1.14
0.46
2.6
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
118
0.67
0.46
1.3
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
626
6376
0.92
0.45
4.9
4.3
mmol/l
4.6
4.7
1.70
573
5881
(3002523) Influenza virus A Ag [Presence] in Specimen
15
112
1.35
0.45
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
731
7224
1.14
0.44
30.2
20.0
e9/l
249.7
249.2
0.08
717
7020
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
31
258
1.21
0.42
6.5
6.6
%
1.6
1.6
0.33
31
244
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
78
701
1.12
0.42
1.6
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
731
7228
1.13
0.42
30.0
19.9
pg
30.3
30.3
0.14
721
7107
(3024731) MCV [Entitic volume]
731
7228
1.13
0.42
30.1
19.9
fl
91.1
90.9
0.52
721
7107
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
29
240
1.22
0.42
1.3
1.7
mg/l
3.8
3.3
0.10
22
178
(3026361) Erythrocytes [#/volume] in Blood
731
7229
1.13
0.41
30.1
20.0
e12/l
4.4
4.5
2.24
713
7007
(3000963) Hemoglobin [Mass/volume] in Blood
731
7231
1.13
0.40
30.3
20.1
g/l
133.7
135.7
2.94
721
7108
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
35
1.43
0.39
1.2
1.5
—
18.6
—
0
5
(3039443) Prostate specific Ag panel - Serum or Plasma
10
137
0.73
0.39
1.3
1.8
—
—
—
0
0
(4146454)
9
69
1.31
0.37
2.4
2.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
69
1.31
0.37
1.1
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
30
253
1.19
0.37
6.7
6.7
%
1.0
0.9
0.76
30
237
(40768806) Pleura Pathology biopsy report
9
71
1.27
0.36
1.6
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
179
0.78
0.36
5.3
4.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
43
1.40
0.35
1.3
1.2
u/l
10.0
11.4
—
6
37
(21494755) Public health laboratory ask at order entry panel
56
625
0.89
0.34
1.4
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
44
1.37
0.34
1.3
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
730
7230
1.11
0.34
30.2
20.0
e9/l
7.0
6.7
1.15
715
7006
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
182
1.21
0.33
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
88
0.68
0.33
1.3
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
110
1.28
0.32
1.1
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
54
599
0.89
0.31
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
98
0.71
0.31
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
250
1.17
0.30
1.7
3.7
g/l
0.3
0.3
—
10
103
(3003694) ABO and Rh group [Type] in Blood
170
1787
0.94
0.29
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
36
317
1.14
0.28
3.7
3.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
112
1.25
0.28
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
76
1.32
0.28
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
63
1.27
0.28
6.1
4.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
95
1.27
0.26
1.0
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
171
0.82
0.26
1.3
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
75
0.66
0.26
2.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
216
1.16
0.25
1.3
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
105
1.24
0.25
1.2
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
76
1.19
0.24
1.3
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
604
6114
0.95
0.23
4.4
3.9
mmol/l
1.3
1.3
0.04
551
5575
(3044242) Glucose [Moles/volume] in Arterial blood
5
38
1.32
0.23
1.4
3.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
39
1.28
0.23
4.0
2.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
2.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
40
1.25
0.22
1.8
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.8
—
0.5
—
0
10
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
5.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
12
0.00
0.21
0.0
3.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
154
1.17
0.21
1.4
1.8
e6/l
30009.8
13417.5
0.34
12
113
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
104
0.77
0.21
2.1
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
52
1.15
0.19
1.7
2.3
ml
595.7
642.2
—
6
29
(3036782) Glucose [Moles/volume] in Pleural fluid
7
59
1.19
0.18
1.0
1.3
mmol/l
6.4
6.5
—
7
54
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
61
1.15
0.17
1.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.3
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
93
1.19
0.14
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
254
0.90
0.14
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
128
0.86
0.13
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
30
277
1.09
0.13
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
116
0.86
0.12
1.1
1.2
u/l
81.7
24.4
—
10
99
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
308
1.07
0.11
3.0
2.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
192
1.10
0.11
1.6
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
176
1722
1.03
0.10
1.8
1.7
mmol/l
1.4
1.4
0.06
148
1444
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
55
1.09
0.09
1.5
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
56
1.07
0.08
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
68
1.03
0.08
1.9
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
90
1.11
0.05
1.3
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
90
1.11
0.05
1.0
1.1
g/l
1.6
1.5
—
10
81
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
150
0.93
0.04
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
170
0.94
0.04
1.3
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
95
1.05
0.00
1.0
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
445
0.99
0.00
2.5
3.0
e9/l
4.3
4.2
0.05
32
355
(4034850)
19
191
0.99
0.00
12.3
9.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
199
1.01
0.00
1.1
1.3
miu/ml
162.5
251.1
—
6
106
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
125
1252
1.00
0.00
2.8
2.9
ug/l
0.7
0.7
0.26
76
810
(3049717) Cytology report of Urine Cyto stain
26
259
1.00
0.00
3.4
2.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
92
0.98
0.00
2.4
2.5
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
65
0.92
0.00
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
90
1.00
0.00
1.3
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
5.4
—
7.8
—
0
7
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
91
0.99
0.00
1.3
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
94
0.96
0.00
2.4
2.5
mmol/l
4.1
4.1
—
9
94
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
89
1.01
0.00
1.3
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
94
0.96
0.00
2.4
2.5
mmol/l
106.8
105.4
—
9
94
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
174.6
—
0
5
(40768441) Liver Pathology biopsy report
5
49
1.02
0.00
2.6
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
82
0.98
0.00
2.1
2.1
pg
33.3
32.8
—
8
82
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
90
1.00
0.00
1.3
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
31.3
—
0
6
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
15.6
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
90
1.00
0.00
1.3
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
2.5
1.9
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_AUTONOM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_AUTONOM | 2.775 [2.37, 3.25] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.162 |
During the follow-up period (1.1.1998 — 31.12.2019), 671 out of 2348 females with G6_AUTONOM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_AUTONOM | 2.517 [2.17, 2.92] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 798 out of 2520 males with G6_AUTONOM died.
Mortality risk
Mortality risk for people of age
years, who have G6_AUTONOM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.269% | 0.529% |
| 5 | 1.548% | 2.991% |
| 10 | 3.906% | 7.184% |
| 15 | 7.323% | 13.304% |
| 20 | 12.638% | 22.103% |
Relationships between endpoints
↥Index endpoint: G6_AUTONOM – Autonomic disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data